Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects
NCT04438720
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Therapeutic Equivalency
Interventions
DRUG:
Extended Release Nifedipine Tablets 30 mg
DRUG:
Extended Release Nifedipine Tablets 30 mg (Adalat® GITS)
Sponsor
Cao Yu